Shadi Abdar Esfahani, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stomach Neoplasms | 3 | 2024 | 1459 | 1.250 |
Why?
|
Radiology | 5 | 2022 | 2113 | 0.990 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2024 | 82 | 0.910 |
Why?
|
Positron-Emission Tomography | 10 | 2024 | 6483 | 0.890 |
Why?
|
Neuroendocrine Tumors | 2 | 2024 | 641 | 0.840 |
Why?
|
Fibrin | 1 | 2024 | 507 | 0.790 |
Why?
|
Collagen Type I | 2 | 2024 | 616 | 0.780 |
Why?
|
Antigens, Surface | 1 | 2024 | 1606 | 0.690 |
Why?
|
Organometallic Compounds | 1 | 2023 | 646 | 0.660 |
Why?
|
Nuclear Medicine | 1 | 2021 | 237 | 0.600 |
Why?
|
Radiation Oncology | 2 | 2022 | 563 | 0.540 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2024 | 1727 | 0.540 |
Why?
|
Gallium Radioisotopes | 3 | 2024 | 195 | 0.480 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2022 | 2008 | 0.460 |
Why?
|
Anal Canal | 2 | 2014 | 374 | 0.450 |
Why?
|
Myoblasts, Skeletal | 1 | 2014 | 75 | 0.450 |
Why?
|
Magnetic Resonance Imaging | 9 | 2024 | 36401 | 0.440 |
Why?
|
Household Articles | 1 | 2012 | 21 | 0.420 |
Why?
|
Cell Tracking | 1 | 2014 | 139 | 0.420 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2016 | 571 | 0.410 |
Why?
|
Ureterocele | 1 | 2011 | 28 | 0.400 |
Why?
|
Granzymes | 2 | 2024 | 277 | 0.400 |
Why?
|
Magnetite Nanoparticles | 1 | 2014 | 316 | 0.400 |
Why?
|
Dextrans | 1 | 2014 | 573 | 0.390 |
Why?
|
Leadership | 1 | 2021 | 1385 | 0.390 |
Why?
|
Epispadias | 1 | 2011 | 19 | 0.390 |
Why?
|
Cystoscopy | 1 | 2011 | 130 | 0.380 |
Why?
|
Cardiac Tamponade | 1 | 2012 | 173 | 0.380 |
Why?
|
Pericardium | 2 | 2012 | 664 | 0.370 |
Why?
|
Urinary Bladder, Neurogenic | 1 | 2012 | 173 | 0.370 |
Why?
|
Heart Injuries | 1 | 2012 | 203 | 0.360 |
Why?
|
Urinary Bladder, Overactive | 1 | 2012 | 114 | 0.360 |
Why?
|
Wounds, Penetrating | 1 | 2012 | 313 | 0.350 |
Why?
|
Myoblasts | 1 | 2011 | 231 | 0.350 |
Why?
|
Bladder Exstrophy | 1 | 2011 | 106 | 0.350 |
Why?
|
Pancreatic Neoplasms | 2 | 2024 | 5369 | 0.340 |
Why?
|
Mice, Nude | 5 | 2024 | 3606 | 0.330 |
Why?
|
Urinary Bladder | 2 | 2012 | 1151 | 0.310 |
Why?
|
Cell Line, Tumor | 8 | 2024 | 16968 | 0.300 |
Why?
|
Urinary Incontinence | 1 | 2011 | 489 | 0.280 |
Why?
|
Rhabdomyosarcoma | 1 | 2009 | 358 | 0.270 |
Why?
|
Copper Radioisotopes | 2 | 2024 | 91 | 0.260 |
Why?
|
Leucovorin | 2 | 2024 | 643 | 0.250 |
Why?
|
Spinal Cord Injuries | 1 | 2012 | 924 | 0.240 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2016 | 2292 | 0.220 |
Why?
|
Infant, Newborn, Diseases | 1 | 2009 | 589 | 0.220 |
Why?
|
Radiography | 3 | 2022 | 6961 | 0.220 |
Why?
|
Mice | 14 | 2024 | 81368 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.210 |
Why?
|
Fluorouracil | 2 | 2024 | 1642 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.200 |
Why?
|
Lactate Dehydrogenases | 1 | 2022 | 26 | 0.200 |
Why?
|
Octreotide | 1 | 2023 | 154 | 0.200 |
Why?
|
Prenatal Diagnosis | 1 | 2009 | 1265 | 0.200 |
Why?
|
Hexokinase | 1 | 2022 | 124 | 0.190 |
Why?
|
Glucose Transporter Type 1 | 1 | 2022 | 186 | 0.190 |
Why?
|
Prostatic Neoplasms | 1 | 2024 | 11107 | 0.190 |
Why?
|
Receptors, Peptide | 1 | 2023 | 279 | 0.190 |
Why?
|
Family Leave | 1 | 2021 | 18 | 0.190 |
Why?
|
Receptor, erbB-3 | 1 | 2022 | 143 | 0.190 |
Why?
|
Lactates | 1 | 2022 | 404 | 0.190 |
Why?
|
Rats, Sprague-Dawley | 1 | 2012 | 8165 | 0.190 |
Why?
|
Pyruvic Acid | 1 | 2022 | 203 | 0.190 |
Why?
|
Animals | 20 | 2024 | 168202 | 0.180 |
Why?
|
Reference Standards | 1 | 2024 | 1003 | 0.180 |
Why?
|
Liver Neoplasms | 1 | 2016 | 4309 | 0.180 |
Why?
|
Organizations | 1 | 2021 | 171 | 0.180 |
Why?
|
Sick Leave | 1 | 2021 | 105 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8652 | 0.180 |
Why?
|
CA-19-9 Antigen | 2 | 2010 | 106 | 0.170 |
Why?
|
Humans | 45 | 2024 | 760740 | 0.170 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2024 | 3599 | 0.170 |
Why?
|
Heart | 1 | 2012 | 4403 | 0.170 |
Why?
|
Disease Models, Animal | 5 | 2016 | 18220 | 0.160 |
Why?
|
Kidney Pelvis | 2 | 2010 | 186 | 0.160 |
Why?
|
Lung Injury | 1 | 2023 | 422 | 0.160 |
Why?
|
Mice, Inbred NOD | 1 | 2023 | 1827 | 0.160 |
Why?
|
Ureteral Obstruction | 2 | 2010 | 293 | 0.150 |
Why?
|
Radiopharmaceuticals | 2 | 2024 | 2650 | 0.140 |
Why?
|
Kidney | 1 | 2013 | 7044 | 0.140 |
Why?
|
Fibrosis | 1 | 2024 | 2047 | 0.140 |
Why?
|
Policy | 1 | 2021 | 506 | 0.140 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2009 | 2223 | 0.140 |
Why?
|
Internship and Residency | 3 | 2022 | 5878 | 0.140 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6927 | 0.140 |
Why?
|
Radiation Injuries | 1 | 2023 | 1189 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1834 | 0.130 |
Why?
|
Carbon Radioisotopes | 1 | 2017 | 561 | 0.130 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2024 | 2423 | 0.130 |
Why?
|
Lactams, Macrocyclic | 1 | 2017 | 318 | 0.130 |
Why?
|
Congresses as Topic | 1 | 2020 | 802 | 0.120 |
Why?
|
Peritoneal Neoplasms | 1 | 2022 | 710 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2022 | 2425 | 0.120 |
Why?
|
Tissue Scaffolds | 2 | 2012 | 932 | 0.120 |
Why?
|
Rabbits | 4 | 2014 | 4770 | 0.120 |
Why?
|
Fluorine Radioisotopes | 1 | 2017 | 418 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11735 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 3 | 2024 | 20556 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2456 | 0.110 |
Why?
|
Burnout, Professional | 1 | 2022 | 703 | 0.110 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2014 | 189 | 0.110 |
Why?
|
Molecular Imaging | 2 | 2023 | 814 | 0.100 |
Why?
|
Cystostomy | 1 | 2012 | 25 | 0.100 |
Why?
|
Treatment Outcome | 9 | 2024 | 64572 | 0.100 |
Why?
|
Matrix Metalloproteinases | 1 | 2015 | 391 | 0.100 |
Why?
|
Breast Feeding | 1 | 2020 | 1355 | 0.100 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2016 | 602 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3769 | 0.100 |
Why?
|
Female | 19 | 2024 | 392203 | 0.100 |
Why?
|
Gastric Outlet Obstruction | 1 | 2012 | 54 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2020 | 1156 | 0.100 |
Why?
|
Urinary Catheterization | 1 | 2012 | 193 | 0.100 |
Why?
|
Play and Playthings | 1 | 2012 | 85 | 0.090 |
Why?
|
Laminectomy | 1 | 2012 | 225 | 0.090 |
Why?
|
Tissue Engineering | 2 | 2012 | 1865 | 0.090 |
Why?
|
Coronary Artery Disease | 1 | 2011 | 6403 | 0.090 |
Why?
|
Gastrointestinal Agents | 1 | 2016 | 510 | 0.090 |
Why?
|
Histiocytosis | 1 | 2011 | 39 | 0.090 |
Why?
|
Male | 20 | 2024 | 360402 | 0.090 |
Why?
|
Urinary Bladder Diseases | 1 | 2011 | 167 | 0.090 |
Why?
|
Ureter | 1 | 2013 | 368 | 0.090 |
Why?
|
DNA Mismatch Repair | 1 | 2013 | 428 | 0.090 |
Why?
|
Iron Overload | 1 | 2012 | 239 | 0.090 |
Why?
|
Guided Tissue Regeneration | 1 | 2010 | 88 | 0.090 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2011 | 269 | 0.090 |
Why?
|
Intestinal Perforation | 1 | 2012 | 249 | 0.080 |
Why?
|
Urodynamics | 1 | 2011 | 344 | 0.080 |
Why?
|
Genital Diseases, Male | 1 | 2010 | 83 | 0.080 |
Why?
|
Quality of Life | 1 | 2011 | 13359 | 0.080 |
Why?
|
beta-Thalassemia | 1 | 2012 | 233 | 0.080 |
Why?
|
Staining and Labeling | 1 | 2014 | 1081 | 0.080 |
Why?
|
Scrotum | 1 | 2010 | 116 | 0.080 |
Why?
|
Chondrocytes | 1 | 2015 | 792 | 0.080 |
Why?
|
Ferritins | 1 | 2012 | 597 | 0.080 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1602 | 0.080 |
Why?
|
Klinefelter Syndrome | 1 | 2009 | 48 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2016 | 15908 | 0.080 |
Why?
|
Graves Disease | 1 | 2010 | 238 | 0.080 |
Why?
|
Hypospadias | 1 | 2009 | 97 | 0.080 |
Why?
|
B-Lymphocyte Subsets | 1 | 2009 | 238 | 0.070 |
Why?
|
Fecal Incontinence | 1 | 2010 | 242 | 0.070 |
Why?
|
Disorders of Sex Development | 1 | 2009 | 128 | 0.070 |
Why?
|
Estradiol | 1 | 2015 | 1937 | 0.070 |
Why?
|
Foreign Bodies | 1 | 2012 | 402 | 0.070 |
Why?
|
Graves Ophthalmopathy | 1 | 2009 | 133 | 0.070 |
Why?
|
Intestines | 1 | 2016 | 1909 | 0.070 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 382 | 0.070 |
Why?
|
Receptors, Estrogen | 1 | 2015 | 2208 | 0.070 |
Why?
|
Transplantation, Autologous | 1 | 2011 | 2112 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1810 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2012 | 1302 | 0.070 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2009 | 629 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 1068 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5672 | 0.060 |
Why?
|
Infant | 6 | 2013 | 36157 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2022 | 14649 | 0.060 |
Why?
|
Esophageal Neoplasms | 1 | 2015 | 1657 | 0.060 |
Why?
|
Biopsy | 2 | 2014 | 6763 | 0.060 |
Why?
|
United States | 3 | 2022 | 72292 | 0.060 |
Why?
|
Cytokines | 2 | 2010 | 7373 | 0.060 |
Why?
|
Contrast Media | 2 | 2017 | 5305 | 0.060 |
Why?
|
Child | 12 | 2012 | 80089 | 0.060 |
Why?
|
Osteoarthritis, Knee | 1 | 2015 | 1234 | 0.060 |
Why?
|
Myeloid Cells | 1 | 2009 | 823 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 8998 | 0.050 |
Why?
|
Neutropenia | 1 | 2009 | 885 | 0.050 |
Why?
|
Image Enhancement | 1 | 2014 | 2881 | 0.050 |
Why?
|
Exercise Test | 1 | 2011 | 2127 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2016 | 3412 | 0.050 |
Why?
|
Tissue Distribution | 2 | 2017 | 2261 | 0.050 |
Why?
|
Tumor Microenvironment | 1 | 2015 | 3868 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 263 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2010 | 1600 | 0.050 |
Why?
|
Bioreactors | 2 | 2012 | 246 | 0.040 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2009 | 1551 | 0.040 |
Why?
|
Lysine | 1 | 2024 | 993 | 0.040 |
Why?
|
Echocardiography | 1 | 2012 | 4987 | 0.040 |
Why?
|
Coronary Angiography | 1 | 2011 | 4470 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2011 | 3356 | 0.040 |
Why?
|
Ultrasonography | 1 | 2011 | 5965 | 0.040 |
Why?
|
Lactation | 1 | 2020 | 397 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2009 | 2896 | 0.040 |
Why?
|
Standard of Care | 1 | 2022 | 551 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12966 | 0.040 |
Why?
|
Iran | 2 | 2011 | 737 | 0.040 |
Why?
|
Interleukin-12 | 2 | 2010 | 577 | 0.040 |
Why?
|
Radiology, Interventional | 1 | 2021 | 476 | 0.030 |
Why?
|
Lactams | 1 | 2017 | 156 | 0.030 |
Why?
|
Rats | 1 | 2012 | 23716 | 0.030 |
Why?
|
Isotope Labeling | 1 | 2017 | 392 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4947 | 0.030 |
Why?
|
Collagen | 1 | 2023 | 2634 | 0.030 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2015 | 68 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2015 | 11069 | 0.030 |
Why?
|
Middle Aged | 3 | 2024 | 220603 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1892 | 0.030 |
Why?
|
Workplace | 1 | 2020 | 863 | 0.030 |
Why?
|
Aged | 2 | 2024 | 169092 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20077 | 0.030 |
Why?
|
Pregnancy | 2 | 2020 | 29869 | 0.030 |
Why?
|
Adolescent | 5 | 2013 | 88247 | 0.030 |
Why?
|
Aminopyridines | 1 | 2017 | 573 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2024 | 2827 | 0.030 |
Why?
|
MutS Homolog 2 Protein | 1 | 2013 | 197 | 0.030 |
Why?
|
Interleukin-2 | 2 | 2010 | 1888 | 0.030 |
Why?
|
Menisci, Tibial | 1 | 2015 | 267 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2010 | 26183 | 0.030 |
Why?
|
Genotype | 3 | 2013 | 12977 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2015 | 1759 | 0.020 |
Why?
|
Indocyanine Green | 1 | 2014 | 233 | 0.020 |
Why?
|
Chelation Therapy | 1 | 2012 | 77 | 0.020 |
Why?
|
Piebaldism | 1 | 2011 | 4 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2010 | 0.020 |
Why?
|
Coloring Agents | 1 | 2014 | 562 | 0.020 |
Why?
|
Interferon-gamma | 2 | 2010 | 3145 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2010 | 17878 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6339 | 0.020 |
Why?
|
Integrases | 1 | 2013 | 518 | 0.020 |
Why?
|
Intestinal Neoplasms | 1 | 2013 | 314 | 0.020 |
Why?
|
Child, Preschool | 5 | 2012 | 42193 | 0.020 |
Why?
|
Social Support | 1 | 2020 | 2174 | 0.020 |
Why?
|
DNA Mutational Analysis | 2 | 2009 | 4110 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 39908 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2017 | 2328 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2013 | 13635 | 0.020 |
Why?
|
Polyglycolic Acid | 1 | 2012 | 406 | 0.020 |
Why?
|
Pigmentation Disorders | 1 | 2011 | 105 | 0.020 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 2010 | 78 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15609 | 0.020 |
Why?
|
Urothelium | 1 | 2012 | 269 | 0.020 |
Why?
|
Interleukin-6 | 2 | 2010 | 3205 | 0.020 |
Why?
|
Brain | 1 | 2016 | 27100 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2013 | 718 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2015 | 834 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2015 | 998 | 0.020 |
Why?
|
Urogenital Surgical Procedures | 1 | 2009 | 33 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2015 | 3088 | 0.020 |
Why?
|
Antigens, CD20 | 1 | 2009 | 199 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2010 | 4340 | 0.020 |
Why?
|
Body Fluids | 1 | 2010 | 320 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2013 | 1125 | 0.020 |
Why?
|
Oral Ulcer | 1 | 2009 | 96 | 0.020 |
Why?
|
Manometry | 1 | 2010 | 453 | 0.020 |
Why?
|
Quinolines | 1 | 2013 | 764 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2015 | 1718 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2015 | 20988 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2015 | 18937 | 0.020 |
Why?
|
Imidazoles | 1 | 2013 | 1175 | 0.020 |
Why?
|
Biofilms | 1 | 2012 | 626 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8619 | 0.020 |
Why?
|
Disease Progression | 2 | 2015 | 13495 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3593 | 0.020 |
Why?
|
Twins, Monozygotic | 1 | 2009 | 470 | 0.020 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2011 | 547 | 0.020 |
Why?
|
Consanguinity | 1 | 2009 | 456 | 0.020 |
Why?
|
Diseases in Twins | 1 | 2009 | 446 | 0.020 |
Why?
|
Pyrazoles | 1 | 2017 | 2008 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2639 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2015 | 1520 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2851 | 0.020 |
Why?
|
Neprilysin | 1 | 2009 | 478 | 0.020 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2016 | 1473 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1483 | 0.020 |
Why?
|
Candidiasis | 1 | 2009 | 365 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3410 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22117 | 0.020 |
Why?
|
Electromyography | 1 | 2010 | 1392 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2014 | 2518 | 0.020 |
Why?
|
Lung | 1 | 2023 | 9999 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3798 | 0.020 |
Why?
|
Eating | 1 | 2012 | 1535 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4512 | 0.010 |
Why?
|
Siblings | 1 | 2009 | 824 | 0.010 |
Why?
|
Neoplasms | 1 | 2013 | 22131 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2009 | 1864 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2013 | 2057 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4117 | 0.010 |
Why?
|
Abdomen | 1 | 2010 | 1128 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2013 | 2863 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2009 | 1185 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2010 | 15250 | 0.010 |
Why?
|
Rare Diseases | 1 | 2009 | 622 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9345 | 0.010 |
Why?
|
Regeneration | 1 | 2012 | 1505 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6074 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2011 | 80583 | 0.010 |
Why?
|
Young Adult | 1 | 2009 | 59191 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3601 | 0.010 |
Why?
|
Adult | 4 | 2022 | 220995 | 0.010 |
Why?
|
Hepatitis C | 1 | 2012 | 1580 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2010 | 22153 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 2009 | 1422 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2013 | 3607 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 4021 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2010 | 5239 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4242 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2010 | 39062 | 0.010 |
Why?
|
Apoptosis | 1 | 2013 | 9476 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 74128 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58919 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2009 | 11512 | 0.010 |
Why?
|
Phenotype | 1 | 2009 | 16572 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 26065 | 0.010 |
Why?
|
Risk Assessment | 1 | 2009 | 23974 | 0.000 |
Why?
|
Mutation | 1 | 2009 | 30015 | 0.000 |
Why?
|